Cargando…

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker Discovery

Alterations in the sphingolipid metabolism of Parkinson’s Disease (PD) could be a potential diagnostic feature. Only around 10–15% of PD cases can be diagnosed through genetic alterations, while the remaining population, idiopathic PD (iPD), manifest without validated and specific biomarkers either...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esfandiary, Ali, Finkelstein, David Isaac, Voelcker, Nicolas Hans, Rudd, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028315/ https://www.ncbi.nlm.nih.gov/pubmed/35456032 http://dx.doi.org/10.3390/cells11081353

Ejemplares similares

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
por: Oftedal, Linn, et al.
Publicado: (2023)

3,4,5‐Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers
por: Vanni, Costanza, et al.
Publicado: (2022)

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
por: Kedariti, Maria, et al.
Publicado: (2022)

GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice
por: van der Lienden, Martijn J. C., et al.
Publicado: (2021)

Dermal fibroblasts from patients with Parkinson’s disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
por: Collins, Lucy M, et al.
Publicado: (2018)

Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2022)

GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
por: Martínez-Bailén, Macarena, et al.
Publicado: (2022)

Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)
por: Clemente, Francesca, et al.
Publicado: (2021)

Brain-penetrant heat shock protein amplifier arimoclomol enhances GCase activity in in vitro Gaucher disease models
por: Hettinghouse, Aubryanna, et al.
Publicado: (2018)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
por: Labrador-Garrido, Adahir, et al.
Publicado: (2023)

Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
por: Davighi, Maria Giulia, et al.
Publicado: (2020)

Solvent Separating Secondary Metabolites Directly from Biosynthetic Tissue for Surface-Assisted Laser Desorption Ionisation Mass Spectrometry
por: Rudd, David, et al.
Publicado: (2015)

Staging of colorectal cancer using lipid biomarkers and machine learning
por: Krishnan, Sanduru Thamarai, et al.
Publicado: (2023)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

Erythrocyte sphingolipid species as biomarkers of Alzheimer's disease
por: Mill, Jericha, et al.
Publicado: (2022)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2019)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

The Equilibria of Sphingolipid-Cholesterol and Sphingolipid–Sphingolipid in Monolayers at the Air–Water Interface
por: Petelska, Aneta Dorota, et al.
Publicado: (2012)

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2020)

Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
por: Motyl, Joanna A., et al.
Publicado: (2021)

The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
por: Blokhin, Victor, et al.
Publicado: (2022)

Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
por: Mah, Michael, et al.
Publicado: (2021)

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
por: Di Pietro, Paola, et al.
Publicado: (2023)

Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
por: Merrill, Alfred H.
Publicado: (2011)

Altered Leukocyte Sphingolipid Pathway in Breast Cancer
por: Maia, Larissa P., et al.
Publicado: (2017)

Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis
por: Burger, Beatriz, et al.
Publicado: (2023)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum
por: Trivedi, Drupad K., et al.
Publicado: (2019)

Gene Pair Correlation Coefficients in Sphingolipid Metabolic Pathway as a Potential Prognostic Biomarker for Breast Cancer
por: Sakharkar, Meena Kishore, et al.
Publicado: (2020)

Lipidomic Analysis of Cervicovaginal Fluid for Elucidating Prognostic Biomarkers and Relevant Phospholipid and Sphingolipid Pathways in Preterm Birth
por: Hong, Se Hee, et al.
Publicado: (2023)

Sphingolipids in Inflammation
por: Albi, Elisabetta, et al.
Publicado: (2018)

Sphingolipids in COPD
por: Chakinala, Raja Chandra, et al.
Publicado: (2019)

Sorting of sphingolipids in the endocytic pathway of HT29 cells
Publicado: (1991)

Sphingolipids activate the endoplasmic reticulum stress surveillance pathway
por: Piña, Francisco, et al.
Publicado: (2018)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
por: McEvoy, Kyle, et al.
Publicado: (2020)

Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity
por: Planas-Serra, Laura, et al.
Publicado: (2023)

The Role of Sphingolipids in Allergic Disorders
por: Díaz-Perales, Araceli, et al.
Publicado: (2021)

Integrated Systems Approach Reveals Sphingolipid Metabolism Pathway Dysregulation in Association with Late-Onset Alzheimer’s Disease
por: Malamon, John Stephen, et al.
Publicado: (2018)

Integrated Chemometrics and Statistics to Drive Successful Proteomics Biomarker Discovery
por: Suppers, Anouk, et al.
Publicado: (2018)

Fungal biomarker discovery by integration of classifiers
por: Saraiva, João Pedro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bi9jnmm7ohoufln7mbjp6nmmec